Following ASCT for multiple myeloma, it is unclear whether relapse is due solely to the presence of residual myeloma cells after myeloablation, or whether it is in part attributable to contamination of the stem cell harvest with viable malignant cells. Positive selection of CD34(+) cells markedly reduces plasma cell contamination. We performed a case controlled analysis in which 15 patients with myeloma who underwent autologous PBSCT with CD34(+) cell selection using the Ceprate System tinder group), were compared with 15 matched controls, All subjects received an identical preparative regimen, The median times to neutrophils greater than or equal to 0.5 x 10(9)/l and unsupported platelets greater than or equal to 50 x 10(9)/l mere 11 and 2...
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for patients w...
We analysed 57 patients with non-myeloid malignancies who received a non-purged autologous PBSCT, Al...
BACKGROUND: Even after high dose chemotherapy (HDT) and autologous haemopoietic stem cell transplant...
Background and Objectives. Positive selection of peripheral blood stem cells (PBSC) has been investi...
10Background and Objectives. Positive selection of peripheral blood stem cells (PBSC) has been inves...
Here we review our recent experience addressing the issue of positive selection and transplantation ...
A potential problem of autologous transplantation in the treatment of multiple myeloma (MM) is the i...
There is a progressive increase in the use of selected hematopoietic progenitor cells after myeloabl...
Background and Objectives: This European Group for Blood and Marrow Transplantation (EBMT) multicent...
Background: We analyzed the hematopoietic reconstitution and outcome of 508 patients with multiple ...
Background: Large-scale CD34+ enrichment has been demonstrated a safe method in autologous transplan...
Abstract Background: Autologous stem cell transplantation is an established treatment option for pa...
BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emph...
Background: Autologous HCT in multiple myeloma is done as upfront treatment in newly diagnosed trans...
Autologous peripheral blood stem cells transplantation (PBSCT) is a therapeutic option which can be ...
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for patients w...
We analysed 57 patients with non-myeloid malignancies who received a non-purged autologous PBSCT, Al...
BACKGROUND: Even after high dose chemotherapy (HDT) and autologous haemopoietic stem cell transplant...
Background and Objectives. Positive selection of peripheral blood stem cells (PBSC) has been investi...
10Background and Objectives. Positive selection of peripheral blood stem cells (PBSC) has been inves...
Here we review our recent experience addressing the issue of positive selection and transplantation ...
A potential problem of autologous transplantation in the treatment of multiple myeloma (MM) is the i...
There is a progressive increase in the use of selected hematopoietic progenitor cells after myeloabl...
Background and Objectives: This European Group for Blood and Marrow Transplantation (EBMT) multicent...
Background: We analyzed the hematopoietic reconstitution and outcome of 508 patients with multiple ...
Background: Large-scale CD34+ enrichment has been demonstrated a safe method in autologous transplan...
Abstract Background: Autologous stem cell transplantation is an established treatment option for pa...
BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emph...
Background: Autologous HCT in multiple myeloma is done as upfront treatment in newly diagnosed trans...
Autologous peripheral blood stem cells transplantation (PBSCT) is a therapeutic option which can be ...
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for patients w...
We analysed 57 patients with non-myeloid malignancies who received a non-purged autologous PBSCT, Al...
BACKGROUND: Even after high dose chemotherapy (HDT) and autologous haemopoietic stem cell transplant...